Newamsterdam Pharma Company N.V. (NAMS)

Newamsterdam Pharma Company N.V.

NAMS

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Viking Global Investors	Equity	6,978,534	$126,381,251	0.37%	0%
Maverick Capital	Equity	1,531,874	$27,742,238	0.43%	+178.79%
Duquesne Family Office	Equity	832,175	$15,071,000	0.39%	+3.98%

Total Shares Held: 9,342,583

Total Value Reported: $169,194,489

Average Allocation per Portfolio 0.39%

Largest Single Portfolio Allocation: 0.43%

Largest Shareholder: Viking Global Investors

Change in Total Shares Held (Q on Q): +1,014,220

Percentage Change in Shares Held (Q on Q): 12.18%

Number of Current Holders: 3

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 2

Number of Funds with Deductions (Q on Q): 0

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 1